Predictors of Non-Relapse Mortality Among Patients Treated with Sirolimus- Vs. Non-Sirolimus-Containing Immune Suppression for Graft-Versus-Host Disease Prevention

Authors :: Brian C. Betts
Lia Perez
Joseph Pidala
Jongphil Kim
Frederick L. Locke
Asmita Mishra
Farhad Khimani
Taiga Nishihori
Ernesto Ayala
Erin Dean
Lu Chen
Claudio Anasetti
Michael Nieder
Hugo F. Fernandez
Melissa Alsina
Jose L. Ochoa-Bayona
Victoria T. Rizk
Mohamed A. Kharfan-Dabaja
Teresa Field
Source :: Biology of Blood and Marrow Transplantation. 22:S402-S403
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Transplantation
medicine.medical_specialty
business.industry
Hematology
medicine.disease
Gastroenterology
Immune system
Graft-versus-host disease
Sirolimus
Internal medicine
Immunology
Medicine
Nonrelapse mortality
business
medicine.drug

Full Text Access

Tools